Tuberculosis chemotherapy: still a double-edged sword.
Chaisson
Richard E
RE
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D015994:Incidence; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D012107:Research Design; D013997:Time Factors
D000995:Antitubercular Agents; D011718:Pyrazinamide